Cargando…
Inter-observer agreement using the LI-RADS version 2018 CT treatment response algorithm in patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization
AIM: To determine inter-reader agreement in categorization of imaging features using the Liver Imaging Reporting and Data System (LI-RADS) treatment response (LR-TR) algorithm in patients with hepatocellular carcinoma (HCC) treated with conventional transarterial chemoembolization (cTACE). METHODS:...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776670/ https://www.ncbi.nlm.nih.gov/pubmed/34581927 http://dx.doi.org/10.1007/s00261-021-03272-9 |
_version_ | 1784636880824827904 |
---|---|
author | Bartnik, Krzysztof Podgórska, Joanna Rosiak, Grzegorz Korzeniowski, Krzysztof Rowiński, Olgierd |
author_facet | Bartnik, Krzysztof Podgórska, Joanna Rosiak, Grzegorz Korzeniowski, Krzysztof Rowiński, Olgierd |
author_sort | Bartnik, Krzysztof |
collection | PubMed |
description | AIM: To determine inter-reader agreement in categorization of imaging features using the Liver Imaging Reporting and Data System (LI-RADS) treatment response (LR-TR) algorithm in patients with hepatocellular carcinoma (HCC) treated with conventional transarterial chemoembolization (cTACE). METHODS: Two radiologists used the LR-TR algorithm to assess 112 computed tomography (CT) examinations of 102 patients treated with cTACE. The inter-observer agreement in categorization of LR-TR features was assessed using kappa (κ) statistics. RESULTS: There was substantial inter-observer agreement between the two reviewers using the LR-TR algorithm (κ = 0.70; 95% CI 0.58–0.81). The two reviewers categorized tumors as non-viable in 37 (33.0%) and 39 (34.8%) of 112 examinations, viable in 58 (51.8%) and 62 (55.4%) examinations, and equivocal in 18 (16.1%) and 11 (9.8%) examinations, respectively. There was almost perfect inter-observer agreement for the LR-TR non-viable category (κ = 0.80; 95% CI 0.68–0.92), substantial agreement for the viable category (κ = 0.78 95% CI 0.67–0.90), and fair agreement for the equivocal category (κ = 0.25; 95% CI 0.02–0.49). CONCLUSION: The LR-TR algorithm conveys high degrees of inter-observer agreement for the assessment of CT imaging features in the viable and non-viable categories. Further refinement of indeterminate features may be necessary to improve the correct categorization of equivocal lesions. GRAPHIC ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-8776670 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-87766702022-02-02 Inter-observer agreement using the LI-RADS version 2018 CT treatment response algorithm in patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization Bartnik, Krzysztof Podgórska, Joanna Rosiak, Grzegorz Korzeniowski, Krzysztof Rowiński, Olgierd Abdom Radiol (NY) Practice AIM: To determine inter-reader agreement in categorization of imaging features using the Liver Imaging Reporting and Data System (LI-RADS) treatment response (LR-TR) algorithm in patients with hepatocellular carcinoma (HCC) treated with conventional transarterial chemoembolization (cTACE). METHODS: Two radiologists used the LR-TR algorithm to assess 112 computed tomography (CT) examinations of 102 patients treated with cTACE. The inter-observer agreement in categorization of LR-TR features was assessed using kappa (κ) statistics. RESULTS: There was substantial inter-observer agreement between the two reviewers using the LR-TR algorithm (κ = 0.70; 95% CI 0.58–0.81). The two reviewers categorized tumors as non-viable in 37 (33.0%) and 39 (34.8%) of 112 examinations, viable in 58 (51.8%) and 62 (55.4%) examinations, and equivocal in 18 (16.1%) and 11 (9.8%) examinations, respectively. There was almost perfect inter-observer agreement for the LR-TR non-viable category (κ = 0.80; 95% CI 0.68–0.92), substantial agreement for the viable category (κ = 0.78 95% CI 0.67–0.90), and fair agreement for the equivocal category (κ = 0.25; 95% CI 0.02–0.49). CONCLUSION: The LR-TR algorithm conveys high degrees of inter-observer agreement for the assessment of CT imaging features in the viable and non-viable categories. Further refinement of indeterminate features may be necessary to improve the correct categorization of equivocal lesions. GRAPHIC ABSTRACT: [Image: see text] Springer US 2021-09-28 2022 /pmc/articles/PMC8776670/ /pubmed/34581927 http://dx.doi.org/10.1007/s00261-021-03272-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Practice Bartnik, Krzysztof Podgórska, Joanna Rosiak, Grzegorz Korzeniowski, Krzysztof Rowiński, Olgierd Inter-observer agreement using the LI-RADS version 2018 CT treatment response algorithm in patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization |
title | Inter-observer agreement using the LI-RADS version 2018 CT treatment response algorithm in patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization |
title_full | Inter-observer agreement using the LI-RADS version 2018 CT treatment response algorithm in patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization |
title_fullStr | Inter-observer agreement using the LI-RADS version 2018 CT treatment response algorithm in patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization |
title_full_unstemmed | Inter-observer agreement using the LI-RADS version 2018 CT treatment response algorithm in patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization |
title_short | Inter-observer agreement using the LI-RADS version 2018 CT treatment response algorithm in patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization |
title_sort | inter-observer agreement using the li-rads version 2018 ct treatment response algorithm in patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization |
topic | Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776670/ https://www.ncbi.nlm.nih.gov/pubmed/34581927 http://dx.doi.org/10.1007/s00261-021-03272-9 |
work_keys_str_mv | AT bartnikkrzysztof interobserveragreementusingtheliradsversion2018cttreatmentresponsealgorithminpatientswithhepatocellularcarcinomatreatedwithconventionaltransarterialchemoembolization AT podgorskajoanna interobserveragreementusingtheliradsversion2018cttreatmentresponsealgorithminpatientswithhepatocellularcarcinomatreatedwithconventionaltransarterialchemoembolization AT rosiakgrzegorz interobserveragreementusingtheliradsversion2018cttreatmentresponsealgorithminpatientswithhepatocellularcarcinomatreatedwithconventionaltransarterialchemoembolization AT korzeniowskikrzysztof interobserveragreementusingtheliradsversion2018cttreatmentresponsealgorithminpatientswithhepatocellularcarcinomatreatedwithconventionaltransarterialchemoembolization AT rowinskiolgierd interobserveragreementusingtheliradsversion2018cttreatmentresponsealgorithminpatientswithhepatocellularcarcinomatreatedwithconventionaltransarterialchemoembolization |